At Abdera, we’re building more than a team. We’re building a community of innovators, leaders, and changemakers dedicated to advancing targeted #radiotherapeutics. Please join us in welcoming Bryan Strouse, our new Director of Portfolio Strategy & New Product Planning. With a deep understanding of #oncology drug development and a clear vision for impact, Bryan is helping shape the future of our portfolio and the potential of our platform. Read what drew him to #TeamAbdera in his own words below.
Abdera Therapeutics
Biotechnology Research
South San Francisco, California 14,938 followers
About us
Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies - one of the most cutting-edge and highly promising areas of drug development. The company is built on a proprietary modular technology platform optimized for the delivery of radioisotopes to selectively destroy tumor cells while sparing healthy cells. Abdera is using this platform to enable the rapid development of a broad range of safe and efficacious therapies serving cancer patients with limited treatment options. Abdera Therapeutics is growing rapidly and seeking key new team members who thrive at the cutting-edge of innovation. Come join us and be a part of the ground-breaking team set to unlock the power of targeted radiotherapy!
- Website
-
http://xmrrwallet.com/cmx.pwww.abderatx.com
External link for Abdera Therapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, California
- Type
- Privately Held
Locations
-
Primary
901 Gateway Blvd
South San Francisco, California 94080, US
-
Vancouver, British Columbia, CA
Employees at Abdera Therapeutics
Updates
-
Lung cancer doesn’t wait, and it impacts hundreds of lives each day. Behind every diagnosis is a person with hopes, loved ones, and a future worth fighting for. On #WorldLungCancerDay, we honor those affected and reaffirm our commitment at Abdera to walk beside you through every step of your cancer journey. Whether you’ve just been diagnosed, are undergoing treatment, or navigating life after cancer, you are not alone.
-
Next week, Abdera Chief Technical Officer Kawa C. will take the stage at the 4th #TRPSummit2025, where she'll be chairing Day 1 and moderating two panel discussions on the role of real-world evidence in trial design and building the talent pipeline to support radiopharma innovation. Kawa brings a deep understanding of discovery and development in targeted radiotherapeutics, and we’re excited for her to share Abdera’s perspective on where the field is headed.
-
-
We’re proud to have Abdera VP of CMC Radiopharmaceutical Development Kevin R. speaking next week at the 4th #TRPSummit2025. Kevin will share insights on regulatory strategies and emerging technologies that can support scalable, sustainable production of #radiotherapeutics, which are critical components of advancing next-generation therapies for solid tumors. Looking forward to a great week of collaboration in San Diego!
-
-
Abdera CSO Rachael Brake was recently featured in STAT's "Up and Down the Ladder", covering the latest comings and goings in biotech. It’s a great read that goes beyond the science. From single-cell sorters to weekend rides, get to know the scientist behind the title. Read more below. https://xmrrwallet.com/cmx.plnkd.in/gmAfNJ2M
-
We are thrilled to welcome Rachael Brake as our Chief Scientific Officer! With more than 20 years of experience building and leading cross-functional teams across research, clinical, and business development, Rachael brings expertise that will help shape the next chapter of our clinical development efforts. As we continue to advance our ROVEr platform and expand our radiopharmaceutical pipeline, her leadership will be instrumental in delivering on our mission to develop potentially best-in-class #cancer medicines. Read more here: https://xmrrwallet.com/cmx.plnkd.in/g9x-9U39
-
-
As we head into Father's Day weekend, we're celebrating the dads of #TeamAbdera and the fathers who helped shape them. Thank you for leading with strength, care, and heart. We're wishing all dads a well-deserved day of recognition and rest. Happy #FathersDay!
-
-
There are three components of targeted #radiotherapeutics: a cancer-targeting molecule, a chelating agent that binds a radioisotope, and a linker connecting them. The goal is for the targeting molecule to seek out and bind tumor cells, delivering the radioisotope to destroy them and limit tumor growth. Powered by a highly potent mechanism of cell killing, the ROVEr platform is uniquely designed to target both high- and low-expressing #cancer markers, ensuring precise and effective delivery of therapeutic radioisotopes. Learn more about our platform at https://xmrrwallet.com/cmx.plnkd.in/gR5GcxDa
-
The San Francisco Business Times Most Influential Women Gala brought together some of the Bay Area’s boldest minds last night, including our CEO Lori Lyons-Williams, who continues to lead Abdera with vision and drive. Congratulations to all the incredible leaders honored!
-
-
Spring is in full swing as the bees are buzzing, the flowers are blooming, and the birds are singing. Happy #MothersDay to all the incredible women out there who balance their lives at home and work with strength and determination. From all of us at Abdera, we hope your day is filled with everything that brings you joy!
-